The present invention features truncated ghrelin analogs active at the GHS receptor.
Ghrelin is a naturally occurring modified peptide. The analogs can bind to the
GHS receptor and, preferably, bring about signal transduction. Ghrelin analogs
have a variety of different uses including being used as a research tool and being
used therapeutically.